Omaxe Ltd
OMAXE NSE
Omaxe Ltd
Consumer DiscretionaryNSE: OMAXE BSE: 532880 Realty
Key Fundamentals
MicrocapResidential Commercial ProjectsRealtyMarket Cap
₹1,246 Cr
Volatility
Moderate
P/E Ratio
-1.9
EBITDA
₹-532 Cr
Debt to Equity
2.54
Book Value
₹-30.45
52W High
₹113.4
52W Low
₹62.5
Technical Indicators
Key Insights
Strengths
1- Debtor days have improved from 112 to 72.5 days.
Weaknesses
3- Company has low interest coverage ratio.
- Company has a low return on equity of -76.3% over last 3 years.
- Contingent liabilities of Rs.2,723 Cr.
Growth Rate
Revenue Growth
0.13% ↗
Net Income Growth
68.70% ↗
Cash Flow Change
2.02% ↗
ROE
-520.28% ↘
ROCE
165.63% ↗
EBITDA Margin (Avg.)
64.54% ↗
Quarterly Results
| Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Depreciation | 16 | 16 | 16 | 10 | 15 | 14 | 7 | 7 | 10 | 12 | 7 | 8 | 9 |
| EPS in Rs | -5.79 | -5.77 | -5.81 | -4.61 | -3.66 | -7.93 | -8.06 | -13.1 | -8.23 | -8.11 | -10.16 | -9.11 | -8.38 |
| Expenses | 346 | 399 | 306 | 333 | 637 | 682 | 493 | 613 | 416 | 647 | 452 | 490 | 457 |
| Interest | 27 | 26 | 31 | 29 | 32 | 38 | 42 | 45 | 57 | 51 | 67 | 65 | 54 |
| Net Profit | -109 | -104 | -106 | -84 | -72 | -144 | -147 | -239 | -150 | -149 | -186 | -166 | -153 |
| OPM % | -42% | -38% | -43% | -25% | -6% | -27% | -44% | -58% | -44% | -20% | -60% | -53% | -51% |
| Operating Profit | -102 | -109 | -93 | -67 | -37 | -146 | -151 | -224 | -127 | -106 | -170 | -169 | -155 |
| Other Income | 10 | 9 | 7 | 4 | 3 | 7 | 44 | 9 | 11 | 12 | 16 | 26 | 17 |
| PBT | -136 | -143 | -132 | -103 | -82 | -191 | -157 | -267 | -183 | -157 | -228 | -216 | -201 |
| Sales | 244 | 289 | 213 | 266 | 599 | 536 | 342 | 389 | 289 | 541 | 282 | 321 | 302 |
| Tax % | -20% | -27% | -19% | -18% | -12% | -25% | -6% | -10% | -18% | -5% | -19% | -23% | -24% |
Profit & Loss
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Depreciation | 10 | 14 | 10 | 9 | 9 | 9 | 73 | 63 | 47 | 65 | 54 | 37 | 36 |
| Div. Payout % | 12% | 15% | 17% | 13% | 15% | 26% | 0% | 0% | 0% | 0% | 0% | 0% | — |
| EPS in Rs | 4.29 | 3.28 | 4.2 | 5.58 | 4.59 | 2.68 | -5.32 | -12.86 | -8.72 | -19.02 | -22.01 | -37.51 | -35.76 |
| Expenses | 1,378 | 1,180 | 1,144 | 1,343 | 1,579 | 1,038 | 924 | 594 | 665 | 1,077 | 1,958 | 2,169 | 2,046 |
| Interest | 131 | 144 | 147 | 155 | 169 | 74 | 108 | 161 | 121 | 113 | 130 | 195 | 237 |
| Net Profit | 79 | 60 | 77 | 105 | 85 | 49 | -97 | -235 | -162 | -351 | -406 | -685 | -654 |
| OPM % | 14% | 17% | 17% | 17% | 14% | 11% | 18% | -25% | -8% | -39% | -21% | -39% | -41% |
| Operating Profit | 226 | 234 | 242 | 284 | 260 | 128 | 198 | -119 | -47 | -303 | -343 | -608 | -600 |
| Other Income | 30 | 34 | 54 | 59 | 59 | 34 | 28 | 39 | 20 | 25 | 21 | 76 | 70 |
| PBT | 116 | 110 | 139 | 179 | 141 | 79 | 44 | -305 | -194 | -457 | -507 | -764 | -803 |
| Sales | 1,605 | 1,414 | 1,386 | 1,627 | 1,839 | 1,167 | 1,121 | 476 | 618 | 773 | 1,614 | 1,561 | 1,446 |
| Tax % | 32% | 46% | 45% | 41% | 39% | 38% | 319% | -23% | -17% | -23% | -20% | -10% | — |
Balance Sheet
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Borrowings | 1,299 | 1,346 | 1,328 | 1,503 | 1,802 | 1,856 | 1,672 | 1,530 | 1,128 | 1,107 | 796 | 796 | 1,419 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Capital | 183 | 183 | 183 | 183 | 183 | 183 | 183 | 183 | 183 | 183 | 183 | 183 | 183 |
| Fixed Assets | 131 | 118 | 600 | 604 | 604 | 599 | 747 | 671 | 627 | 582 | 565 | 606 | 595 |
| Investments | 16 | 20 | 22 | 12 | 12 | 12 | 12 | 12 | 13 | 14 | 29 | 21 | 20 |
| Other Assets | 6,306 | 6,769 | 7,091 | 7,710 | 7,512 | 10,149 | 9,789 | 10,359 | 11,278 | 12,964 | 13,228 | 14,264 | 15,112 |
| Other Liabilities | 3,225 | 3,585 | 4,353 | 4,704 | 4,129 | 7,163 | 7,239 | 8,108 | 9,545 | 11,555 | 12,546 | 14,300 | 14,866 |
| Reserves | 1,746 | 1,794 | 1,848 | 1,936 | 2,014 | 1,558 | 1,456 | 1,222 | 1,062 | 715 | 298 | -388 | -740 |
| Total Assets | 6,453 | 6,908 | 7,712 | 8,326 | 8,128 | 10,760 | 10,549 | 11,042 | 11,918 | 13,560 | 13,822 | 14,891 | 15,728 |
| Total Liabilities | 6,453 | 6,908 | 7,712 | 8,326 | 8,128 | 10,760 | 10,549 | 11,042 | 11,918 | 13,560 | 13,822 | 14,891 | 15,728 |
Cash Flow
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CFO/OP | 76 | 170 | 54 | 58 | 21 | 336 | 332 | -468 | -1,695 | -149 | -290 | -174 |
| Financing | -152 | -391 | -105 | -173 | -35 | -435 | -783 | -517 | -740 | -262 | -924 | -770 |
| Investing | 11 | -6 | 6 | 20 | 21 | 16 | 106 | 23 | -22 | -142 | -64 | -126 |
| Operating | 139 | 362 | 91 | 121 | 19 | 400 | 638 | 566 | 783 | 469 | 987 | 1,007 |
| Free Cash Flow | 121 | 352 | 76 | 102 | 5 | 393 | 636 | 570 | 782 | 458 | 985 | 999 |
| Net Cash Flow | -2 | -34 | -7 | -32 | 4 | -18 | -39 | 72 | 21 | 65 | -1 | 111 |
Ratios
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Conversion Cycle | 197 | 199 | 208 | 235 | 158 | 110 | 111 | 298 | 227 | 182 | 14,539 | 73 |
| Days Payable | — | — | — | — | — | — | — | — | — | — | 1,755 | — |
| Debtor Days | 197 | 199 | 208 | 235 | 158 | 110 | 111 | 298 | 227 | 182 | 81 | 73 |
| Inventory Days | — | — | — | — | — | — | — | — | — | — | 16,214 | — |
| ROCE % | 8% | 8% | 9% | 10% | 8% | 4% | 5% | -5% | -3% | -16% | -23% | -61% |
| Working Capital Days | 470 | 601 | 570 | 547 | 461 | 532 | 508 | 911 | 424 | 156 | -62 | -333 |
Documents
Financial Year 2012
from nse
from nse
Financial Year 2013
from nse
from nse
Financial Year 2014
from bse
from bse
Financial Year 2016
from bse
from bse
Financial Year 2015
from bse
from bse
Financial Year 2013
from bse
from bse
Financial Year 2025
from bse
from bse
Financial Year 2024
from bse
from bse
Financial Year 2023
from bse
from bse
Financial Year 2022
from bse
from bse
Financial Year 2021
from bse
from bse
Financial Year 2020
from bse
from bse
Financial Year 2019
from bse
from bse
Financial Year 2018
from bse
from bse
Financial Year 2017
from bse
from bse
Concall - Nov 2017
Nov 2017
Concall - Nov 2015
Nov 2015
Concall - May 2018
May 2018
Concall - May 2016
May 2016
Concall - Jun 2017
Jun 2017
Concall - Jul 2020
Jul 2020
Concall - Feb 2018
Feb 2018
Concall - Feb 2017
Feb 2017
Concall - Feb 2016
Feb 2016
Concall - Dec 2016
Dec 2016
Concall - Aug 2017
Aug 2017
Concall - Aug 2015
Aug 2015
Closure of Trading Window
9h - Trading window closed from April 1, 2026 until 48 hours after audited FY2025-26 results.
9h - Trading window closed from April 1, 2026 until 48 hours after audited FY2025-26 results.
Intimation With Respect To Project Launch And Regulatory Approvals
8h - Wholly-owned subsidiaries received RERA registrations for Omaxe World Mall and The Retreat on 17-03-2026.
8h - Wholly-owned subsidiaries received RERA registrations for Omaxe World Mall and The Retreat on 17-03-2026.
Intimation With Respect To Project Launch And Regulatory Approvals.
8h - Omaxe subsidiary received RERA registration for four Mohali residential projects launched 12.03.2026, valid till 2030.
8h - Omaxe subsidiary received RERA registration for four Mohali residential projects launched 12.03.2026, valid till 2030.
Announcement under Regulation 30 (LODR)-Press Release / Media Release
6 Mar - Sold out 173 residences and 120 commercial units; projects ₹1,060 crore; completion Aug/Dec 2030.
6 Mar - Sold out 173 residences and 120 commercial units; projects ₹1,060 crore; completion Aug/Dec 2030.
Announcement under Regulation 30 (LODR)-Press Release / Media Release
6 Mar - Sold out 173 residences and 120 commercial units; projects ₹1,060 crore; completion Aug/Dec 2030.
6 Mar - Sold out 173 residences and 120 commercial units; projects ₹1,060 crore; completion Aug/Dec 2030.
Intimation With Respect To Project Launch And Regulatory Approval
6 Mar - Omaxe subsidiary's 'URBAN SQUARE-14' (Mohali) received RERA registration PBRERA-SAS80-PC0414-032026; launch 07.03.2026; valid till 31-12-2028.
6 Mar - Omaxe subsidiary's 'URBAN SQUARE-14' (Mohali) received RERA registration PBRERA-SAS80-PC0414-032026; launch 07.03.2026; valid till 31-12-2028.
Intimation With Respect To Project Launch And Regulatory Approval
6 Mar - Omaxe subsidiary's 'URBAN SQUARE-14' (Mohali) received RERA registration PBRERA-SAS80-PC0414-032026; launch 07.03.2026; valid till 31-12-2028.
6 Mar - Omaxe subsidiary's 'URBAN SQUARE-14' (Mohali) received RERA registration PBRERA-SAS80-PC0414-032026; launch 07.03.2026; valid till 31-12-2028.
Intimation With Respect To Project Launch And Regulatory Approval
5 Mar - Omaxe subsidiary got RERA registration for The Lake Commercial Phase 2 (Mohali) PBRERA-SAS80-PC0410-022026, launched 05.03.2026.
5 Mar - Omaxe subsidiary got RERA registration for The Lake Commercial Phase 2 (Mohali) PBRERA-SAS80-PC0410-022026, launched 05.03.2026.
Intimation With Respect To Project Launch And Regulatory Approval
5 Mar - Omaxe subsidiary got RERA registration for The Lake Commercial Phase 2 (Mohali) PBRERA-SAS80-PC0410-022026, launched 05.03.2026.
5 Mar - Omaxe subsidiary got RERA registration for The Lake Commercial Phase 2 (Mohali) PBRERA-SAS80-PC0410-022026, launched 05.03.2026.
Closure of Trading Window
26 Mar - Trading window closed from April 1, 2026 until 48 hours after audited FY2025-26 results.
26 Mar - Trading window closed from April 1, 2026 until 48 hours after audited FY2025-26 results.
Announcement under Regulation 30 (LODR)-Allotment
26 Feb - Allotted 185 secured NCDs on Feb 26, 2026 totaling Rs18.5 crore; issue up to Rs199.4 crore.
26 Feb - Allotted 185 secured NCDs on Feb 26, 2026 totaling Rs18.5 crore; issue up to Rs199.4 crore.
Announcement under Regulation 30 (LODR)-Press Release / Media Release
25 Mar - Names 1,500+ 'Pink Stand' after Harmanpreet Kaur; ₹2,500 crore, 30,000-seater Omaxe State development.
25 Mar - Names 1,500+ 'Pink Stand' after Harmanpreet Kaur; ₹2,500 crore, 30,000-seater Omaxe State development.
Announcement under Regulation 30 (LODR)-Newspaper Publication
23 Mar - Copy of newspaper publication w.r.t. Special Window for Re-lodgement of transfer request of physical shares.
23 Mar - Copy of newspaper publication w.r.t. Special Window for Re-lodgement of transfer request of physical shares.
Intimation With Respect To Project Launch And Regulatory Approvals
21 Mar - Two wholly‑owned subsidiaries received RERA registrations for Phase 6B and Metro City P‑8B; launch date 23-03-2026.
21 Mar - Two wholly‑owned subsidiaries received RERA registrations for Phase 6B and Metro City P‑8B; launch date 23-03-2026.
Intimation With Respect To Project Launch And Regulatory Approval.
20 Mar - RERA registration for METRO CITY P-2 A (Lucknow); reg. no. UPRERAPRJ222879/03/2026; launch 21-Mar-2026; valid till 09-Oct-2027.
20 Mar - RERA registration for METRO CITY P-2 A (Lucknow); reg. no. UPRERAPRJ222879/03/2026; launch 21-Mar-2026; valid till 09-Oct-2027.
Intimation With Respect To Project Launch And Regulatory Approvals
16 Mar - Wholly-owned subsidiaries received RERA registrations for Omaxe World Mall and The Retreat on 17-03-2026.
16 Mar - Wholly-owned subsidiaries received RERA registrations for Omaxe World Mall and The Retreat on 17-03-2026.
Announcement under Regulation 30 (LODR)-Press Release / Media Release
13h - Names 1,500+ 'Pink Stand' after Harmanpreet Kaur; ₹2,500 crore, 30,000-seater Omaxe State development.
13h - Names 1,500+ 'Pink Stand' after Harmanpreet Kaur; ₹2,500 crore, 30,000-seater Omaxe State development.
Rating update
8 Aug 2024 from care
8 Aug 2024 from care
Rating update
7 Jul 2025 from infomerics
7 Jul 2025 from infomerics
Rating update
5 Jul 2024 from care
5 Jul 2024 from care
Rating update
27 Aug 2024 from care
27 Aug 2024 from care
Rating update
24 Sep 2024 from care
24 Sep 2024 from care
Rating update
1d from smera
1d from smera
Frequently Asked Questions about Omaxe Ltd
What does Omaxe Ltd do?
Omaxe ltd. is in the business of developing real estate properties for residential, commercial and retail purposes with a presence across 27 cities in 8 states of India. It has undertaken various projects in the areas of contractual construction, township development, building of commercial compl...
Where is Omaxe Ltd (OMAXE) listed?
Omaxe Ltd is listed on the Indian stock exchanges. It is listed on NSE: OMAXE and BSE: 532880. You can view its live share price, financials, and ratios on Tapetide.
Which sector does Omaxe Ltd belong to?
Omaxe Ltd operates in the Consumer Discretionary sector within the Realty industry. Sector classification helps investors compare companies affected by similar economic conditions and regulatory changes.
What is the market capitalisation of Omaxe Ltd?
Omaxe Ltd has a market capitalisation of approximately ₹1245.92 Cr. Based on this, it is classified as a Small Cap stock.
What is the PE ratio of Omaxe Ltd?
The Price-to-Earnings (PE) ratio of Omaxe Ltd is -1.90. The PE ratio compares a company's share price to its earnings per share and is commonly used to assess whether a stock is overvalued or undervalued relative to its peers.
What is the 52-week high and low of Omaxe Ltd?
Over the past 52 weeks, Omaxe Ltd has traded between a low of ₹62.5 and a high of ₹113.4. This range helps investors understand the stock's price volatility and recent trading levels.
How can I research Omaxe Ltd on Tapetide?
On Tapetide, you can view Omaxe Ltd's live share price, quarterly results, profit & loss statements, balance sheet, cash flow, key ratios, shareholding pattern, technical indicators, analyst ratings, and forecasts — all on a single page without needing to sign up.
Company Information
Omaxe ltd. is in the business of developing real estate properties for residential, commercial and retail purposes with a presence across 27 cities in 8 states of India. It has undertaken various projects in the areas of contractual construction, township development, building of commercial complexes, multi-storied apartments, etc. [1] [2]
Website omaxe.com
CEO Mr. Rohtas Goel
Employees 484
Listed 2007-08-09
Face Value ₹ 10
Issued Size 18,29,00,540